THE USE OF CHEMOTHERAPEUTIC AGENTS IN THE TREATMENT OF CHILDHOOD CANCER.
D000305:Adrenal Cortex Hormones; D000963:Antimetabolites; D000970:Antineoplastic Agents; D002648:Child; D006689:Hodgkin Disease; D006801:Humans; D007223:Infant; D007938:Leukemia; D008207:Lymphatic Metastasis; D015122:Mercaptopurine; D008727:Methotrexate; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000532:radiotherapy*; D009447:Neuroblastoma; D009588:Nitrogen Mustard Compounds; D014116:Toxicology; D014750:Vincristine
D000305:Adrenal Cortex Hormones; D000963:Antimetabolites; D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D014750:Vincristine; D015122:Mercaptopurine; D008727:Methotrexate
ADRENAL CORTEX HORMONES; ANTIMETABOLITES; ANTINEOPLASTIC AGENTS; CHILD; HODGKIN'S DISEASE; INFANT; LEUKEMIA; LYMPHATIC METASTASIS; MERCAPTOPURINE; METHOTREXATE; NEOPLASM METASTASIS; NEOPLASM RADIOTHERAPY; NEUROBLASTOMA; NITROGEN MUSTARD COMPOUNDS; TOXICOLOGIC REPORT; VINCRISTINE